Kendal K. Whitlock

Kendal K. Whitlock is the Former Head of Digital Optimization, RWE Clinical Trials, with Walgreens.
In this senior leadership role, she leveraged data assets and partnerships to advance culturally
responsive approaches to clinical research. In her biopharma tenure, Kendal’s focus has been the
application of digital health solutions to drive access and opportunities for flexible and convenient
participation in clinical trials. Kendal’s impact is based on more than two decades of pharmaceutical
industry experience in delivering patient-centered results. She has worked globally in digital clinical
trials, through a rare experience in both medical affairs and market access roles. She holds a Master
of Public Health degree in Sociomedical Sciences from Columbia University and is currently working
toward a doctorate. Kendal earned a BA with honors from Spelman College. She is an expert
speaker, has published in peer-reviewed journals, is an executive advisor to the PATIENTS program
for the University of Maryland School of Pharmacy, NIH/Bill and Melinda Gates Women’s Health
R&D Innovation Equity Forum (2023-) Steering Committee member, and formerly, past Co-
Lead, Decentralized Trials Research Alliance (DTRA), 3C DCT Research Curriculum Initiative
(2021-2023), past Chair, Product Development & Clinical Research Sub-committee, Med Tech
Color Collaborative Community (2021-2024), among the Diversity Women Media’s Elite 100
Class of 2023, the Inaugural Kerry Murphy Healey (KMH) Center for Health Innovation Award
Recipient (Babson College), and the 2024 National Coalition of 100 Black Women – Greater
Cleveland Chapter, Inc.’s Women of Vision Honoree in Health.

Past Events

• Panelist: MedtechVISION 2022 – Remote Clinical Trials: Transitioning from the Traditional to the Modern